Daniel Ewing

589 total citations
13 papers, 389 citations indexed

About

Daniel Ewing is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Daniel Ewing has authored 13 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Epidemiology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Daniel Ewing's work include Mosquito-borne diseases and control (6 papers), Viral Infections and Outbreaks Research (5 papers) and Influenza Virus Research Studies (3 papers). Daniel Ewing is often cited by papers focused on Mosquito-borne diseases and control (6 papers), Viral Infections and Outbreaks Research (5 papers) and Influenza Virus Research Studies (3 papers). Daniel Ewing collaborates with scholars based in United States, Sweden and Indonesia. Daniel Ewing's co-authors include Kevin R. Porter, Kanakatte Raviprakash, Irving A. Phillips, Gerald S. Murphy, Alfonso S. Gozalo, Douglas M. Watts, Walter R. Weiss, Kevin L. Russell, Tadeusz J. Kochel and Shuenn-Jue Wu and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Microbiology.

In The Last Decade

Daniel Ewing

13 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Ewing United States 9 284 271 60 47 29 13 389
Cindy Tamminga United States 7 210 0.7× 221 0.8× 53 0.9× 54 1.1× 44 1.5× 11 393
M Leal Brazil 10 213 0.8× 258 1.0× 101 1.7× 31 0.7× 26 0.9× 23 371
Kavita Diddi India 5 177 0.6× 190 0.7× 56 0.9× 19 0.4× 15 0.5× 5 317
Esther M. Ellis United States 14 323 1.1× 421 1.6× 72 1.2× 31 0.7× 43 1.5× 31 568
Laurent Chambonneau France 11 437 1.5× 478 1.8× 51 0.8× 22 0.5× 16 0.6× 15 546
Helen Oh Singapore 11 315 1.1× 351 1.3× 73 1.2× 21 0.4× 27 0.9× 17 483
Rafael De La Barrera United States 13 477 1.7× 563 2.1× 74 1.2× 34 0.7× 19 0.7× 18 614
Cheng-Lin Deng China 14 278 1.0× 260 1.0× 70 1.2× 58 1.2× 68 2.3× 17 466
Timothy Burgess United States 11 509 1.8× 579 2.1× 52 0.9× 48 1.0× 68 2.3× 15 652
Jayantha Liyanage United States 8 177 0.6× 173 0.6× 116 1.9× 99 2.1× 18 0.6× 9 316

Countries citing papers authored by Daniel Ewing

Since Specialization
Citations

This map shows the geographic impact of Daniel Ewing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ewing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ewing more than expected).

Fields of papers citing papers by Daniel Ewing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ewing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ewing. The network helps show where Daniel Ewing may publish in the future.

Co-authorship network of co-authors of Daniel Ewing

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ewing. A scholar is included among the top collaborators of Daniel Ewing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ewing. Daniel Ewing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sanders, John W., Daniel Ewing, David A. Ornelles, et al.. (2024). Immunogenicity and Protective Efficacy of Psoralen-Inactivated SARS-CoV-2 Vaccine in Nonhuman Primates. Vaccines. 12(5). 451–451. 1 indexed citations
2.
3.
Ewing, Daniel, Ying Cheng, Peifang Sun, et al.. (2021). Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice. Pathogens. 10(5). 626–626. 8 indexed citations
4.
Ponzio, Todd A., Joseph Goodman, David L. Caudell, et al.. (2020). Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands. Tropical Diseases Travel Medicine and Vaccines. 6(1). 10–10. 2 indexed citations
5.
Ewing, Daniel, Kanakatte Raviprakash, Gabriel Defang, et al.. (2020). Comparison of purified psoralen-inactivated and formalin-inactivated dengue vaccines in mice and nonhuman primates. Vaccine. 38(17). 3313–3320. 22 indexed citations
6.
Schaecher, Kurt E., et al.. (2019). Nosocomial outbreak of influenza A H3N2 in an inpatient oncology unit related to health care workers presenting to work while ill. American Journal of Infection Control. 47(6). 683–687. 30 indexed citations
7.
Burgess, Timothy, Clinton K. Murray, Mary Bavaro, et al.. (2015). Self-administration of intranasal influenza vaccine: Immunogenicity and volunteer acceptance. Vaccine. 33(32). 3894–3899. 16 indexed citations
8.
Burgess, Timothy, Clinton K. Murray, Mary Bavaro, et al.. (2014). 1162Self-administration of intranasal influenza vaccine: immunogenicity and volunteer acceptance. Open Forum Infectious Diseases. 1(suppl_1). S345–S345. 2 indexed citations
9.
Porter, Kevin R., Daniel Ewing, Lan Chen, et al.. (2011). Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine. Vaccine. 30(2). 336–341. 58 indexed citations
10.
Kochel, Tadeusz J., Douglas M. Watts, Alfonso S. Gozalo, et al.. (2005). Cross‐Serotype Neutralization of Dengue Virus inAotusnancymaeMonkeys. The Journal of Infectious Diseases. 191(6). 1000–1004. 46 indexed citations
11.
Raviprakash, Kanakatte, Douglas M. Watts, Alfonso S. Gozalo, et al.. (2000). A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys. Vaccine. 18(27). 3166–3173. 90 indexed citations
12.
Raviprakash, Kanakatte, Kevin R. Porter, Daniel Ewing, et al.. (2000). Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques. Microbiology. 81(7). 1659–1667. 86 indexed citations
13.
Porter, Kevin R., John R. Mascola, Daniel Ewing, et al.. (1997). Genetic, Antigenic and Serologic Characterization of Human Immunodeficiency Virus Type 1 from Indonesia. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14(1). 1–6. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cindy Tamminga Breakdown of academic impact, for papers by M Leal Breakdown of academic impact, for papers by Kavita Diddi Breakdown of academic impact, for papers by Esther M. Ellis Breakdown of academic impact, for papers by Laurent Chambonneau Breakdown of academic impact, for papers by Helen Oh Breakdown of academic impact, for papers by Rafael De La Barrera Breakdown of academic impact, for papers by Cheng-Lin Deng Breakdown of academic impact, for papers by Timothy Burgess Breakdown of academic impact, for papers by Jayantha Liyanage
Rankless by CCL
2026